Pei-Hung Chang

20PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursPacific Peoples epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 10, 2026
Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.

|Jun 19, 2026
Trifluridine/tipiracil and survival in mismatch repair-deficient metastatic colorectal cancer.

|Oct 28, 2024
Astragalus polysaccharides improve adjuvant chemotherapy-induced fatigue for patients with early breast cancer.

Wen-Chi Shen, Shin-Cheh Chen, Cheng-Hsu Wang

|Mar 13, 2024
Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy.

Pei-Hung Chang, Hung-Yi Chen, Yueh-Shih Chang

|Aug 12, 2023
Axitinib Rechallenge Restores the Anticancer Effect after Nivolumab: A Case Report.

Yueh-Shih Chang, Pei-Hung Chang, Deng-Huang Wang

|Nov 08, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.

Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang

Pageof 4

Frequent Collaborators

7 joint publications

Wen-Chi Chou

4 joint publications

Jason Chia-Hsun Hsieh

4 joint publications

Hang Huong Ling

4 joint publications

Kun-Yun Yeh